Page 42 - BH-2-3

Brain & Heart Digital tools for stroke and bleeding risk in AF

Management of Atrial Fibrillation of the European Society doi: 10.7326/0003-4819-131-12-199912210-00004
of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
35. Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L.
doi: 10.1093/eurheartj/ehq278 Biomarkers in atrial fibrillation: A clinical review. Eur Heart
27. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ J. 2013;34(20):1475-1480.
HRS guideline for the management of patients with atrial doi: 10.1093/eurheartj/eht024
fibrillation: Executive summary: A report of the American 36. Hijazi Z, Lindbäck J, Alexander JH, et al. The ABC (age,
College of Cardiology/American Heart Association Task
Force on practice guidelines and the Heart Rhythm Society. biomarkers, clinical history) stroke risk score: A biomarker-
Circulation. 2014;130(23):2071-2104. based risk score for predicting stroke in atrial fibrillation.
Eur Heart J. 2016;37(20):1582-1590.
doi: 10.1161/CIR.0000000000000040
doi: 10.1093/eurheartj/ehw054
28. Mulder BA, van Veldhuisen DJ, Rienstra M. What should
the C (“congestive heart failure”) represent in the CHA2 37. Berg DD, Ruff CT, Jarolim P, et al. Performance of the ABC
DS2 -VASc score? Eur J Heart Fail. 2020;22(8):1294-1297. Scores for assessing the risk of stroke or systemic embolism
and bleeding in patients with atrial fibrillation in ENGAGE
doi: 10.1002/ejhf.1946 AF-TIMI 48. Circulation. 2019;139(6):760-771.
29. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC doi: 10.1161/CIRCULATIONAHA.118.038312
Guidelines for the diagnosis and treatment of acute and
chronic heart failure: The Task Force for the diagnosis and 38. Fox KAA, Lucas JE, Pieper KS, et al. Improved risk
treatment of acute and chronic heart failure of the European stratification of patients with atrial fibrillation: an integrated
Society of Cardiology (ESC) Developed with the special GARFIELD-AF tool for the prediction of mortality, stroke
contribution of the Heart Failure Association (HFA) of the and bleed in patients with and without anticoagulation. BMJ
ESC. Eur Heart J. 2016;37(27):2129-2200. Open. 2017;7(12):e017157.
doi: 10.1093/eurheartj/ehw128 doi: 10.1136/bmjopen-2017-017157
30. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ 39. Shin SY, Han SJ, Kim JS, et al. Identification of markers
ACCP/HRS guideline for the diagnosis and management associated with development of stroke in “clinically
of atrial fibrillation: A report of the American college of low-risk” atrial fibrillation patients. J Am Heart Assoc.
cardiology/American Heart association joint committee 2019;8(21):e012697.
on clinical practice guidelines. Circulation. 2024;149(1):e1- doi: 10.1161/JAHA.119.012697
e156.
40. Vasunilashorn S, Crimmins EM, Kim JK, et al. Blood lipids,
doi: 10.1161/CIR.0000000000001193 infection, and inflammatory markers in the Tsimane of
31. Kotecha D, Chudasama R, Lane DA, Kirchhof P, Lip GYH. Bolivia. Am J Hum Biol. 2010;22(6):731-740.
Atrial fibrillation and heart failure due to reduced versus doi: 10.1002/ajhb.21074
preserved ejection fraction: A systematic review and meta-
analysis of death and adverse outcomes. Int J Cardiol. 41. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al.
2016;203:660-666. Validation and refinement of scores to predict very early
stroke risk after transient ischaemic attack. Lancet Lond
doi: 10.1016/j.ijcard.2015.10.220 Engl. 2007;369(9558):283-292.
32. Ariyaratnam JP, Lau DH, Sanders P, Kalman JM. Atrial doi: 10.1016/S0140-6736(07)60150-0
fibrillation and heart failure: Epidemiology, pathophysiology,
prognosis, and management. Card Electrophysiol Clin. 42. Claxton JS, MacLehose RF, Lutsey PL, et al. A new model
2021;13(1):47-62. to predict ischemic stroke in patients with atrial fibrillation
using warfarin or direct oral anticoagulants. Heart Rhythm.
doi: 10.1016/j.ccep.2020.11.004
2019;16(6):820-826.
33. Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme doi: 10.1016/j.hrthm.2018.12.005
to predict ischemic stroke and other thromboembolism in
atrial fibrillation: The ATRIA study stroke risk score. J Am 43. Graves KG, May HT, Knowlton KU, et al. Improving
Heart Assoc. 2013;2(3):e000250. CHA2DS2-VASc stratification of non-fatal stroke and
mortality risk using the Intermountain Mortality Risk
doi: 10.1161/JAHA.113.000250
Score among patients with atrial fibrillation. Open Heart.
34. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, 2018;5(2):e000907.
Singer DE. Warfarin use among ambulatory patients with doi: 10.1136/openhrt-2018-000907
nonvalvular atrial fibrillation: The anticoagulation and risk
factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 44. Horne BD, Jacobs V, May HT, Graves KG, Bunch TJ.
1999;131(12):927-934. Augmented intelligence decision tool for stroke prediction

Volume 2 Issue 3 (2024) 19 doi: 10.36922/bh.3068